Mechanism of Endothelial Dysfunction in Obstructive Sleep Apnea (OSA)

NCT01027078 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2022-06-28

No results posted yet for this study

Summary

The investigators hypothesized that patients with Obstructive Sleep Apnea (OSA) who are free of any cardiovascular disease will have early microcirculatory changes that are unique to OSA, and therefore would resolve with treatment of OSA.

Conditions

Sponsors & Collaborators

  • Ohio State University

    lead OTHER

Principal Investigators

  • Rami Khayat, MD · Ohio State University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2022-02-04
Completion
2022-02-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01027078 on ClinicalTrials.gov